The current study
evaluates antidiabetic, anticoagulant, and antiplatelet
activity of novel benzimidazole-containing quinolinyl oxadiazoles.
These derivatives are synthesized and characterized using spectroscopy
(FT-IR, 1H NMR, and mass spectroscopy) and single-crystal
X-ray diffraction methods. The inhibitory effects of these compounds
were evaluated by the α-glucosidase inhibitory assay and shows
the activity in the range of IC50 = 0.66 ± 0.05 to
3.79 ± 0.46 μg/mL. In addition, molecular docking studies
revealed that benzimidazole-containing quinolinyl oxadiazoles can
correctly dock into the target receptor protein of the human intestinal α-glucosidase, while their bioavailability/drug-likeness
was predicted to be acceptable but requires further optimization.
On the other hand, compound 8a and 8d showed
anticoagulant activity as they enhanced the clotting time from control
180–410 and 180–390 s, respectively, in platelet rich
plasma and 230–460 and 230–545 s in platelet poor plasma.
Furthermore, only 8a showed antiplatelet activity by
inhibiting epinephrine-induced platelet aggregation, and the observed
aggregation inhibition was found to be 93.4%. Compounds 8a–f show nontoxic properties because of the non-hydrolyzing properties
in the RBC cells. In addition, 8a and 8d show anti-edema and anti-hemorrhagic properties in the experimental
mice. These findings reveal that benzimidazole-containing quinolinyl
oxadiazoles act as α-glucosidase inhibitors to develop novel
therapeutics for treating type-II diabetes mellitus and can act as
lead molecules in drug discovery as potential antidiabetic and antithrombotic
agents.
Introduction: Oxidative stress plays a critical role in the progression of diabetes, arthritis, cancer, eryptosis, cardiovascular disease, and thrombosis. Currently, antioxidants from natural sources are in high demand due to their beneficial role in the management of said diseases.
Aim: The purpose of the study was to evaluate the protective effect of sorghum protein buffer extract (SBE) on sodium nitrite-induced oxidative stress and thrombosis.
Materials and methods: Protein characterization of SBE was done using SDS-PAGE. Oxidative stress in RBC was induced using sodium nitrite (NaNO2) and the key stress markers such as lipid peroxidation (LPO), protein carbonyl content (PCC), and the level of antioxidant enzymes (SOD and CAT) were measured. The anticoagulant effect of SBE was identified by employing in-vitro plasma recalcification time, activated partial thromboplastin time (APTT), prothrombin time (PT), and in-vivo mouse tail bleeding time. SBE antiplatelet activity was examined using agonist adenosine diphosphate (ADP) and epinephrine-induced platelet aggregation. Non-toxic property of SBE was identified using in-vitro direct haemolytic, haemorrhagic, and edema forming activities using experimental mice.
Results: SBE revealed similar protein banding pattern under both reduced and non-reduced conditions on SDS-PAGE. Interestingly, SBE normalized the level of LPO, PCC, SOD, and CAT in stress-induced RBCs. Furthermore, SBE showed anticoagulant effect in platelet rich plasma by enhancing the clotting time from the control 250 s to 610 s and bleeding time from the control 200 s to more than 500 s (p<0.01) in a dose dependent manner. In addition, SBE prolonged the clot formation process of only APTT but not PT. SBE inhibited the agonists ADP and epinephrine induced platelet aggregation. SBE did not hydrolyze RBC cells, devoid of edema and haemorrhage properties.
Conclusions: This study demonstrates for the first time the anticoagulant, antiplatelet, and antioxidant properties of SBE. Thus, the observed results validate consumption of sorghum as good for health and well-being.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.